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Abstract
Background: Emerging evidence indicates that inappropriate cell-cell fusion might contribute to cancer progression.
Similarly, mesenchymal stem cells (MSCs) can also fuse with other cells spontaneously and capable of adopting the
phenotype of other cells. The aim of our study was to investigate the role of MSCs participated cell fusion in the
tumorigenesis of gastric cancer.
Methods: We fused human umbilical cord mesenchymal stem cells (hucMSCs) with gastric cancer cells in vitro
by polyethylene glycol (PEG), the hybrid cells were sorted by flow cytometer. The growth and migration of
hybrids were assessed by cell counting、cell colony formation and transwell assays. The proteins and genes
related to epithelial- mesenchymal transition and stemness were tested by western
blot、immunocytochemistry and real-time RT-PCR. The expression of CD44 and CD133 was examined by
immunocytochemistry and flow cytometry. The xenograft assay was used to evaluation the tumorigenesis of
the hybrids.
Results: The obtained hybrids exhibited epithelial- mesenchymal transition (EMT) change with down-regulation of E-
cadherin and up-regulation of Vimentin, N-cadherin, α-smooth muscle actin (α-SMA), and fibroblast activation protein
(FAP). The hybrids also increased expression of stemness factors Oct4, Nanog, Sox2 and Lin28. The expression of CD44
and CD133 on hybrid cells was stronger than parental gastric cancer cells. Moreover, the migration and proliferation of
heterotypic hybrids were enhanced. In addition, the heterotypic hybrids promoted the growth abilities of gastric
xenograft tumor in vivo.
Conclusions: Taken together, our results suggest that cell fusion between hucMSCs and gastric cancer cells
could contribute to tumorigenic hybrids with EMT and stem cell-like properties, which may provide a flexible
tool for investigating the roles of MSCs in gastric cancer.
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Background
Mesenchymal stem cells (MSCs) represent a subset of
non-hematopoietic adult stem cells, which exhibit the
potential to differentiate to diverse lineages, such as
bone, adipose and cartilage tissues [1, 2]. In addition to
the roles in tissue repair and regeneration, MSCs have
been suggested as a critical component in tumor
microenvironment, in which the soluble factors pro-
duced by inflammatory and tumor cells will recruit
MSCs to the tumor sites [3]. Our previous study has
demonstrated that bone marrow derived MSCs are re-
cruited to the site of growing tumors and promote
tumor growth in mouse xenograft models [4–6], sug-
gesting that the interaction between MSCs and tumor
cells is critical for tumor progression. However, the
underlying mechanism remains unclear.
Cell fusion, a complex and highly regulated process in
which two or more cells become one by merging their
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plasma membranes, plays critical roles in several physio-
logical (fertilization, tissue regeneration) and pathophysio-
logical (viral infection, cancer) events [7]. More and more
findings have proposed that cell fusion may be involved in
tumor progression [8–12]. The hybrids of cell fusion can be
more malignant than their parental cells and possess en-
hanced ability to metastasize [13–15]. A model of “wolf in
sheep’s clothing” is proposed to explain the link between
cell fusion and metastasis. This model suggests that tumor
cells become metastatic by fusion with normal cells that
travel throughout the body freely [16]. For instance, tumor
associated macrophage may fuse with epithelial cancer cells
at the sites of primary tumor, giving rise to hybrids that
have enhanced migratory and invasive capabilities [17].
MSCs are considered as one of the pivotal elements in
the tumor microenvironment as well as a promising
fusogenic candidate [18]. So, whether MSCs could merge
with other cells, pre-malignant cells or cancer cells, and
play an important role in the occurrence of tumor. A
stem cell fusion model has emerged as a classical mech-
anism for tumor development. This model suggests that
a fusion event between bone marrow-derived stem cell
(BMDSC) and pre-malignant cells give rise to cancer
[19]. Also, MSCs can fuse with different cancer cells
spontaneously at low frequency. Several studies have
shown that the hybrids between pre-malignant cell and
stem cells are more malignant than the parental cells
and gain self-renewal and migratory abilities, which
highlight the pro-tumor role of stem cells by fusing with
other cells [20–23].
Gastric cancer is the fourth most common cancer and
the second leading cause of cancer-related death world-
wide [24]. In our previous studies, we found that after
treatment with gastric cancer cell-derived exosomes,
hucMSCs differentiated into carcinoma-associated fibro-
blasts (CAFs) [25]. We have also previously reported
that hucMSCs activated by macrophages promote both
gastric epithelial cells and gastric cancer cells prolifera-
tion and migration [26]. However, few researches have
been done into the effect of cell fusion of MSCs with
gastric cancer cells on gastric carcinoma. In the present
study we fused hucMSCs with gastric cancer cells and
investigated the effect of fusion with hucMSCs on the
biological properties of gastric cancer cells. We found
that the hybrids of mesenchymal stem cells and gastric
cancer cells contributed to highly malignant both with
EMT and stem-cell like properties.
Methods
Ethics statement
Ethical and methodological aspects of the investigation
protocols were approved by the ethical committee of
Jiangsu University (2012258).
Cell culture
Human gastric cancer cell lines HGC-27 and SGC-7901
were purchased from Cell Bank,Type Culture Collection
Committee,Chinese Academy of Sciences (Shanghai,
China). HGC-27 cells and SGC-7901 cells were main-
tained in high-glucose DMEM (H-DMEM, Life tech-
nologies, USA) with 10 % FBS. HucMSCs were obtained
and identified as previously described [27]. HucMSCs
were maintained in low-glucose DMEM (L-DMEM, Life
technologies) with 10 % FBS. Cells were all incubated at
37 °C in humidified cell culture incubator with 5 % CO2
and the medium was changed every 3 days after the ini-
tial plating.
Cell fusion and sorting
Gastric cancer cells (HGC-27 or SGC-7901) and
hucMSCs were labeled with DIO and DID fluorescent
dye following the manufacturer’s instructions (Life tech-
nologies), respectively. The hybrids of DIO-labeled gas-
tric cancer cells (1 × 106) and DID-labeled hucMSCs
(1 × 105) were generated by using PEG1500 (Roche,
USA). The fusion cells were plated in L-DMEM with
10 % FBS, cultured for 2 days, and then sorted by flow
cytometer (SORP Aria II, BD Biosciences, USA). The
double-positive hybrid cells were collected in L-DMEM
containing 10 % FBS, penicillin and streptomycin. The
sorted fused cells were collected and cultured in a 96-
well plate using limiting dilution method for single cell
sub-cloning.
Flow cytometry and imaging
The DIO-labeled HGC-27 cells/SGC-7901 cells and
DID-labeled hucMSCs was fused by PEG1500 in vitro
and suspended in 200 μl PBS. Then the cell suspensions
were analyzed on the Image Stream X Mark IIimaging
flow cytometer (Merck Millipore) with low flow rate/
high sensitivity. The cell suspensions were acquired im-
mediately and single cell populations were gated for de-
tect the fused cells and unfused cells visually. Four
fluorescence channels were visualized in the INSPIRE
software: Brightfield images were collected in CH1, DIO
fluorescence was recorded using excitation with a
488 nm laser (CH2), and DID fluorescence using excita-
tion with a 640 laser (CH11). A total of 3000–5000 cell
events were collected for each sample. Single stained
controls were also collected (DIO only and DID only la-
belled cells) at the same settings in order to develop a
compensation matrix for removing spectral overlap of
dyes from each of the channels.
Cell counting
The parental and fusion cells were seeded into 24-
well plate (1 × 104 cells/well) overnight. The cells were
collected and counted at the indicated time points
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(24, 48, 72 and 96 h). The results are the mean
values of three independent experiments.
Colony forming assay
The parental or fusion cells were harvested and plated
into a 6-well plate (2 × 103 cells/well) and incubated at
37 °C in humidified cell culture incubator with 5 % CO2
for 15 days. The medium was changed every 3 days. To
evaluate the number of colonies, the cultures were fixed
with 4 % para-formaldehyde and stained with crystal vio-
let. The results are the mean values of three independent
experiments.
Cell invasion and migration
The parental or fusion cells (1 × 105 cells in serum free-
DMEM medium) were seeded into the upper chamber,
and medium containing 10 % FBS was added to the
lower chamber. After incubation at 37 °C in 5 % CO2 for
12 h, the cells that invaded and migrated to the lower
surface of the membrane were fixed with 4 % para-
formaldehyde and stained with crystal violet for 15 min.
This experiment was performed in triplicate.
Western blot
Cells were homogenized and lysed in RIPA buffer sup-
plemented with proteinase inhibitor. Equal amount of
proteins (150 μg) were loaded and run on 12 % SDS-
PAGE gel, then transferred onto PVDF membranes fol-
lowing electrophoresis. After blocked with 5 % milk in
TBS/T for 1 h, membranes were incubated with the pri-
mary antibodies at 4 °C overnight. The sources of pri-
mary antibodies were: anti-E-cadherin and anti-N-
cadherin (Santa Cruz Biotechnology, CA, USA); anti-
Oct4, anti-Sox2, anti-Nanog, anti-Vimentin (Signalway
Antibody, USA); anti-PCNA, anti-Cyclin D1 (Bioworld
Technology, Louis Park, MN, USA). GAPDH (Cwbio,
Beijing, China) was used as the loading control.
Real-time RT-PCR
Total RNA was extracted using Trizol reagent (Life tech-
nologies, Carlsbad, CA, USA) according to the manufac-
turer’s instructions and equal amount of RNA was used
for real-time PCR analyses. The cDNAs were synthesized
by using a reverse transcription kit (Vazyme, Nanjing,
China). β-actin was used as the internal control. The se-
quences of specific primers are listed in Table 1.
Immunofluorescence
Cells cultured in 24-well chamber slides were washed
twice with cold PBS, fixed with 4 % para-formaldehyde for
15 min, permeabilized with 0.1 % Triton X-100 for 5 min,
blocked with 5 % BSA, incubated with indicated primary
antibodies(anti-CD44 and anti-α-SMA, Bioworld Tech-
nology) at 4 °C overnight and followed by a Cy3-
conjugated anti-rabbit secondary antibody (Cwbio,
Beijing, China). The cells were then stained with Hoechst
33342 for nuclear staining, and the images were acquired
with a Nikon eclipse Ti-S microscope (Nikon, Tokyo,
Japan).
Flow cytometry
The expression of CD133 antigen on hybrids and paren-
tal gastric cancer cells were performed by flow cytome-
try. Cells were stained with PE-conjugated monoclonal
anti-human CD133 (Becton Dickinson). Isotype control
IgG-PE (San Jose, CA) served as a control. After stained
30 min, samples were analyzed by flow cytometry (FACS
Calibur, BD) and data were analyzed using CellQuest
software (BD Biosciences).
H&E staining
The neoplasm tissues (4 mm2) were deparaffinated then
gradually dehydrated, embedded in paraffin, the tissue
Table 1 List of primer sequences
Genes
name
Forward primer Tm(°C) Length(bp)
Reverse primer
Oct4 TTGAGGCTCTGCAGCTTAG 60 285
GCCGGTTACAGAACCACAC
Sox2 ACACCAATCCCATCCACACT 60 224
GCAAACTTCCTGCAAAGCTC
Nanog CCTGATTCTTCCACCAGTCC 60 292
TGCTATTCTTCGGCCAGTTG
Lin28 ACCGGACCTGGTGGAGTATT 60 204
CTTCAGCGGACATGAGGCTA
E-cadherin CGCATTGCCACATACACTCT 60 252
TTGGCTGAGGATGGTGTAAG
N-cadherin AGTCAACTGCAACCGTGTCT 60 337
AGCGTTCCTGTTCCACTCAT
vimentin GAGCTGCAGGAGCTGAATG 60 344
AGGTCAAGACGTGCCAGAG
α -SMA CTGACTGAGCGTGGCTATTC 58 452
CCACCGATCCAGACAGAGTA
FAP ATAGCAGTGGCTCCAGTCTC 59 278
GATAAGCCGTGGTTCTGGTC
Slug CCTGGTTGCTTCAAGGACAC 60 395
TCCATGCTCTTGCAGCTCTC
snail GGTTCTTCTGCGCTACTGCT 59 285
TAGGGCTGCTGGAAGGTAAA
twist GTCCGCAGTCTTACGAGGAG 60 294
TGGAGGACCTGGTAGAGGAA
β-actin CACGAAACTACCTTCAACTCC 56 265
CATACTCCTGCTTGCTGATC
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sections (4 μm) were stained by H&E staining for light
microscopy.
Xenograft assay
Twelve male BALB/C nude mice (4–6 weeks) were pur-
chased from Laboratory Animal center of Shanghai and
were randomly divided into 6 mice per group. Both
groups were injected subcutaneously of either HGC-27
or HGC-27 fusion cells (2 × 106 cells in 200 μl PBS).
Tumor growth was evaluated by measuring the length
and width of the tumor mass with calipers every 2 days.
Tumor volumes were calculated by the modified ellips-
oidal formula: (length × width2) /2.
Statistical analysis
Statistical analysis of the data was performed by using
GraphPad Prism 5 software. All the data were expressed
as mean ± SD. The means of different treatment groups
were compared by two-way ANOVA or the Student’s t
test. P value <0.05 was considered statistically significant.
Results
Fusion of gastric cancer cells with hucMSCs generates
hybrid cells
To facilitate the identification of cell fusion events, fu-
sion partners were labeled with cytomembrane fluores-
cent dyes DIO (for HGC-27 and SGC-7901 cells) and
DID (for hucMSCs). Cell fusion was induced by
Fig. 1 Cell fusion between hucMSCs and gastric cancer cells. a. Cell sorting of HGC27-hucMSC fused cells by flow cytometry. HGC-27 and hucMSCs were
labeled with DIO and DID, respectively. DIO-HGC27 and DID-hucMSC was collected respectively. The control group indicates spontaneous fusion while
the fusion represents the PEG1500-mediated generation of double positive hybrids. b. The statistical analyses of fusion efficiency. The data represent mean
± SD of three independent experiments. *P< 0.05,***P< 0.001 (c) Microscopic fluorescent images of fused cells. (a) The single double-positive hybrid was
detected on the third day after sorting. Scale bar 100 μm, Magnification: ×200; (b) Hybrids with two nuclei were stained with Hoechst 33342 (blue) and cell
membrane structures were double-labeled (yellow) were observed on the seventh day after sorting. Scale bar 100 μm, Magnification:
×200. d. Representative images from the cell population gates were tested by imaging cytometer. HGC-27 and hucMSCs were stained with DIO (green)
and DID (red), respectively. In the “unfused”group, under the treatment of PEG1500, the two cells formed an adhesion structure but not a hybrid. Also,
the hybrids fused with DIO-HGC27 and DID-HucMSCs are yellow and showed in the“fused” group. The double positive cell populations were gated in R2,
the population of hybrids was 8.08 %
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PEG1500 in co-cultured DIO-HGC27 and DID-
hucMSCs. After culture for 24 h in vitro, the hybrids
(double-stained cells) were detected and sorted by dual
color (DIO and DID) fluorescence activated cell sorting
(FACS) for initial enrichment of the hybrid cells (Fig. 1a).
sThe cell sorting experiment of DIO-SGC7901 and DID-
hucMSCs was also tested (Additional file 1). The fusion
efficiency was about 6.033 ± 1.408 % in HGC-27 cells
and 4.067 ± 0.033 % in SGC-7901 cells (Fig. 1b). The
statistical data was listed in Table 2. The sorted fused
cells were collected and cultured 96-well plate using lim-
iting dilution method for single cell sub-cloning. After
culture for 3 days, the dual fluorescent binucleate hy-
brids were identified by confocal microscope (Fig. 1c).
The cell fusion event and cell fusion efficiency was also
demonstrated by imaging flow cytometer (Fig. 1d), which
combines the digital fluorescence microscopy with speed
and sensitivity of flow cytometry. The flow cytometry and
imaging of cell fusion event between SGC-7901 and
hucMSCs was showed (Additional file 2). The single
double-positive hybrid in a well was selected and cultured
for expansion. Then, we obtained the cell lines and named
it HGC-27 fusion. The SGC-7901 fusion cell lines were
obtained in the same way.
Cell fusion enhanced growth of gastric cancer cells
Morphological observation showed that the parental
gastric cancer cells displayed rounded and elongated
morphologies, respectively. After fusion with hucMSCs,
the hybrid cells lost epithelial morphology, became scat-
tered and exhibited a fibroblast-like appearance with an
elongated shape and started to grow as bundles (Fig. 2a).
To further investigate the effect of cell fusion on cell
growth ability, we compared in vitro growth rates of the
hybrid cells with that of their parental gastric cancere
cells by cell counting assay. At the fourth day after cell
seeding, the number of hybrid cells was markedly higher
than that of their parental cells (Fig. 2b). The proliferat-
ing ability of the hybrid cells was determined by colony
forming assay. Statistical results showed that the hybrid
cells grew faster and formed more colonies than parental
cells (3–4 folds) (Additional file 3). We also examined
the expression of PCNA and cell cycle regulatory protein
(CyclinD1) by western blot. We found that PCNA and
Table 2 Cell fusion efficiency of control and fusion group
HGC-27(%) SGC-7901(%)
control fusion control fusion
1 1.7 4.2 1.2 4.0
2 1.0 5.1 1.3 4.1
3 0.6 8.8 0.9 4.1
Fig. 2 Fusion with hucMSCs induces morphological changes and enhanced growth of gastric cancer cells. a. The two gastric cancer cell lines
showed epithelial morphology and hucMSCs with fibroblast-like shape. HGC-27 fusion hybrids exhibit elongated shape and front-to-back polarity.
SGC-7901 fusion lost the epithelial morphology and assumed a fibroblast-like appearance. Scale bar 100 μm, Magnification: ×100. b. The growth
of the parental and hybrid cells was determined by cell counting assay. c. The expression of PCNA and CyclinD1 proteins in parental and hybrid
cells was examined by western blot
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CyclinD1 levels were significantly increased in fusion cells
(Fig. 2c). In summary, these data suggest that cell fusion
enhances the growth ability of gastric cancer cells in vitro.
Cell fusion promoted EMT of gastric cancer cells
Due to the morphological changes of MSC-gastric can-
cer cell hybrids, we hypothesized that the fused cells
might undergo an epithelial to mesenchymal transition.
To this end, transwell migration assay and wound heal-
ing assay was carried out to determine the migratory
ability of the cell hybrids. In transwell migration assay,
the number of HGC-27 fusion cells migrating through
the transwell membrane was more migratory (3.2-fold)
compared of HGC-27 cells. The number of SGC-7901
fusion cell hybrids migrating through the transwell
membrane was more 4.1-fold than that of SGC-7901
cells (Fig. 3a and b). To investigate whether EMT-
associated genes are differentially expressed between the
fused cells and the parental cells, we used western blot
and real-time RT-PCR to determine the expression of
EMT related proteins and genes in fused cells and par-
ental cells. The results of western blot revealed that the
fused cells exhibited an obvious decrease in E-cadherin
expression while increase in the expression of vimentin
and N-cadherin compared to their parental gastric can-
cer cells (Fig. 3c). The results of real-time RT-PCR re-
vealed that the level of E-cadherin mRNA in hybrids was
obviously down-regulated but the expression of mesen-
chymal markers (α-SMA, FAP, vimentin, N-cadherin,
snail, slug, and twist) in fusion cells were evidently in-
creased (Fig. 3d). In summary, these data suggest that,
after fusion with hucMSCs, the migratory ability of gas-
tric cancer cells is changed markedly and indicates the
hybrid cells experience the process of EMT.
Cell fusion increased gastric cancer cell stemness
Our present results demonstrate that the hybrid cells
may have undergone an epithelial-mesenchymal transi-
tion,recent studies have demonstrated that EMT plays a
key role in generating cancer stem cells. So, whether our
hybrid cells could acquire stem cell properties? To valid-
ate it, we performed real-time RT-PCR, western blot to
determine the stemness of the cell hybrids. First, we
tested cancer stem cell surface marker CD44 by im-
munofluorescence. Obviously, the expression of CD44
on hybrid cells was stronger than the parental gastric
cancer cells (Fig. 4a). CD133, a member of prominin
family, was first discovered in hematopoietic stem cells,
Fig. 3 Fusion with hucMSCs induces EMT in gastric cancer cells. a. Transwell migration assay of parental and hybrid cells. b. The number of migrated
cells in transwell migration assay. ***P < 0.001. c. The expression of mesenchymal markers E-cadherin、N-cadherin and Vimentin was determined by
western blot. d. The expression of EMT-related genes was determined by real-time RT-PCR
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and served as one of the most widely reported marker of
cancer stem cells. To determine whether the hybrid cells
possess the cancer stem cell properties, we first assessed
the expression of CD133 on hybrids and parental gastric
cancer cells by flow cytometry. CD133 expression in-
creased in hybrids compared with the parental cells (in-
crease from 0.1 to 1.5 % in HGC-27 fusion and 0.2 to
2.5 % in SGC-7901 fusion) (Fig. 4b). The expression of
stemness factors including Oct4, Sox2, Nanog and Lin28,
which are known to be sufficient to reprogram somatic
cells to pluripotent stem cells, were found to be signifi-
cantly increased in fused cells compared to the parental
gastric cancer cells by western blot and real-time RT-PCR
(Fig. 4c and d). All these results indicate that the hybrid
cells may acquire multiple traits of stem cells.
Cell fusion enhanced growth of gastric cancer cells in vivo
To investigate whether cell fusion of gastric cancers and
hucMSCs could promotes cancer growth in vivo. We
used HGC-27 cells and HGC-27 fusion cells to establish
xenograft tumor models in nude mice. The images of
tumor-bearing mice were shown (Fig. 5a). In the HGC-
27 fusion group, tumor nodule started to form at the
4 days after injection while the HGC-27 cells group was
not observed. As shown in (Fig. 5b, c and d), the tumor
weight and volume in HGC-27 fusion group was higher
than that in the HGC-27 group. The neoplasm tissues of
hybrids presented highly heterogeneity, abnormally ele-
vated nuclear/cytoplasmic ratios, and derangement dis-
tribution in some regions (Additional file 4). Taken
together, these results suggest that cell fusion between
gastric cancer cells and hucMSCs enhances gastric can-
cer growth in vivo.
Discussion
During the process of tumor progression, tumor cells
can detach from the primary tumor site and spread to
other parts of the body and colonize distant organ sites.
Although a number of routes to metastasize have been
proposed, the precise underlying mechanisms still
Fig. 4 Fusion with hucMSCs induces the acquisition of stemness in gastric cancer cells. a. Immunofluorescent staining of CD44 in the parental and the
hybrid cells. b. The expression of cancer stem cell marker CD133 in the parental and hybrid cells was determined by flow cytometry. c. The
expression of Oct4, Sox2, Nanog proteins in the parental and hybrid cells was determined by western blot. d. The expression of Oct4, Sox2,
Nanog, and Lin28 in the hybrid cells related to the parental cells was examined by real-time RT-PCR
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remain elusive. Recently, a prominent theory has emerged,
which states that a tumor cell could fuse with a mobile cell
type and then travel to another site in the body to estab-
lish cancer. This classic theory is called “cancer cell fu-
sion” [28], which first regard cell fusion event as a possible
mechanism of tumor metastasis. Pawelek et al. fused the
healthy macrophages with weakly metastatic melanoma
cells and found that most of the experimental hybrids
were highly metastatic and lethal when implanted into
mice [29]. Not only in animal model, they also give sub-
stantiated reports for cancer cell fusion in human, in
which a melanoma brain metastasis with a donor-patient
hybrid genome following bone marrow transplantation
[30]. Thus, cell fusion event is regarded as a hidden force
or a hidden enemy in cancer.
Similar to “cancer cell fusion” theory, another model
has been proposed in recent years. The stem cell fusion
model focuses on the role of BMDCs (including MSCs)
in cell fusion event. This hypothesis proposes that fusion
between BMDCs and “altered” tissue cells/pre-malignant
cells would result in malignant tumors, which may be
more migratory and more invasive. BM-MSC could be a
putative fusion candidate and are known to specifically
migrate to and engraft at inflammation or tumor sites.
Several studies have reported that MSCs could fuse with
variety of target cells and generate the tumorigenic hy-
brids after fusion. Houghton et al. reported that bone
marrow derived cells are the origin of gastric cancer in
helicobacter-infected mice [31]. MSCs may be recruited
to the Helicobacter Pylori-infected gastric mucosa where
they fuse with existing neoplastic and pre-neoplastic epi-
thelial cells. Fusion of MSC with gastric epithelial cells
increases invasion and metastasis of gastric cancer [32].
The spontaneous formation of BM-MSCs and lung/
breast cancer hybrids acquire the tumorigenic and meta-
static properties as well as mesenchymal characteristic
[15, 22]. In addition, the hybrids of HepG2 cells and
MSCs after PEG mediated fusion are more metastatic
in vivo than MSCs and HepG2 [23]. In contrary, there
are some studies showing that fusion of MSCs with
esophageal carcinoma cells inhibits the tumorigenicity of
esophageal carcinoma cells [33].
In this report, we fused human umbilical cord mesen-
chymal stem cells with gastric cancer cells by PEG1500
to obtain hybrids in vitro. PEG is a widely used agent for
cell fusion because of its simplicity and low cost. More-
over, cell fusion mediated by PEG is an efficient proced-
ure for obtaining somatic cell hybrids and widely used in
monclonal antibody production. PEG could induce cell
agglutination and cell-to-cell contact, leading to subse-
quent cell fusion. However, the detailed mechanisms
underlying the PEG-mediated cell fusion are not known.
In natural process, cell fusion is also a common event,
compared with PEG-induced cell fusion, in natural
process, cell fusion is a basic physiological activities and
complex and highly regulated process, and the rate of
cell fusion event is very rare. The aritifical fusion process
such as PEG-induced cell fusion also has its limitation,
Fig. 5 Hybrids of HGC-27 cell promote gastric cancer growth in vivo. a. The representative images of tumor-bearing mice. b. Tumor tissues were
photographed 20 days after tumor cell inoculation. c, d. The weight and volume of tumor issues removed from HGC-27 and HGC-27
fusion groups. ***P < 0.0001
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PEG can cause the uncontrollable fusion of multiple
cells, leading to the appearance of giant polykaryons. In
addition, standard PEG-mediated cell fusion is pooly re-
producible, and different cell types have varible fusion
susceptibilities.
Our present results demonstrate that cell fusion be-
tween hucMSCs and gastric cancer cells generates a
population of tumorigenic hybrids, which exhibit mesen-
chymal phenotypes and properties from MSCs along
with increased metastatic capacity. The fused cells
expressed higher levels of markers and regulatory pro-
teins associated with epithelial to mesenchymal transi-
tion such as vimentin, α-SMA, and FAP, and exhibited
an enhanced invasiveness and motility in transwell assay.
This indicates that cell fusion event may induce an
epithelial-mesenchymal transition (EMT) in the hybrids.
EMT is an essential step in the process of cancer cell
dissemination and metastasis. Recent work reveals that
the process of EMT generates cells with stem cell like
properties in the mammary cell population [34], which
puts forward the cell fusion hypothesis of cancer stem
cells [35]. Fusion events may result in the transient in-
duction of an EMT in large population of cancer cells
and simultaneously induces the generation of CSCs. The
cell fusion hypothesis of CSCs adds an important func-
tional underpinning to the potential multifaceted roles
of cell fusion in the initiation and progression of cancers
[36, 37]. However, opinions differ as to whether cell fu-
sion would generate CSCs. Fan et al. have shown that fu-
sion between human bone hematopoietic stem cells and
esophageal cancer cell might not contribute to the origin
of cancer stem cells [38]. Our present data showed that
the hybrids highly expressed stemness genes such as
Oct4, Sox2, Nanog and Lin28 compared to the parental
cells, indicating that the hybrids may acquire cancer
stem cell properties after cell fusion. In our results, com-
pared with the expression of EMT and stemenss proteins
in gastric cancer cells and hucMSCs, the hybrid cells
were somewhere in between. The results suggest that
hybrid cells could acquire the mesenchymal and stem-
ness proteins during a physical fusion event with MSCs.
Although the hybrid cells have both EMT and stem cell-
like properties, future work are warranted to ascertain
whether the tumorigenic hybrids are cancer stem cells.
Therefore, more attention should be paid to the cell fu-
sion event in the cancer research in the future, especially
the involvement of MSCs participated cell fusion in car-
cinogenesis. Blocking cell fusion within cancerous tissues
would prevent the origin of more malignant tumor hy-
brid cells [39].
Conclusions
The current results of our study demonstrated that cell
fusion between hucMSCs and gastric cancer cells could
give rise to a subpopulation of hybrid cells exhibiting an
altered phenotype, including the morphological changes
with a fibroblast-like appearance as well as the capability
of both EMT and stem-cell like properties.
Additional files
Additional file 1: Flow cytometry analysis and sorting of hybrids. SGC-
7901 cells were labeled with DIO, hucMSCs were labeled with DID. The
control group was the mock fused stained cells. The double positive fused
cells were sorted and collected for the subsequent research. (TIFF 854 kb)
Additional file 2: Representative images from each of the cell
population gates. DIO-labeled SGC-7901 showed green, DID-labeled
hucMSCs showed red (upper panel). In the fusion cell populations, the un-
fused cells and fused cells that with double-positive and yellow color were
displayed in the lower panel. (TIFF 1104 kb)
Additional file 3: Representative images of cell colonies for HGC-27
and SGC-7901 parental and hybrid cells. (A) The proliferating ability of
the hybrid cells was determined by colony forming assay. (B) Statistical
results showed that the hybrid cells grew faster and formed more
colonies than parental cells (3–4 folds). (TIFF 1834 kb)
Additional file 4: Histological images of tumor from a mouse injected
with the HGC-27 cells and HGC-27 fusion cells. Magnification, ×400.
(TIFF 3256 kb)
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